Cimzia and Retinal deposits - a phase IV clinical study of FDA data

Summary:

Retinal deposits is reported as a side effect among people who take Cimzia (certolizumab pegol), especially for people who are female, 50-59 old, also take Humira,.

The phase IV clinical study analyzes which people have Retinal deposits when taking Cimzia. It is created by eHealthMe based on reports of 106,367 people who have side effects when taking Cimzia from the FDA, and is updated regularly.

What is Cimzia?

Cimzia has active ingredients of certolizumab pegol. It is often used in rheumatoid arthritis. eHealthMe is studying from 106,745 Cimzia users. Check the latest studies of Cimzia.

What is Retinal deposits?

Retinal deposits is found to be associated with 21 drugs and 67 conditions by eHealthMe. Check the latest studies of Retinal deposits.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

106,367 people reported to have side effects when taking Cimzia.
Among them, 31 people (0.03%) have Retinal deposits.

Among these 31 people:

What is the gender of people who have Retinal deposits when taking Cimzia? *

female: 100 %
male: 0.0 %

What is the age of people who have Retinal deposits when taking Cimzia? *

What are other drugs people take besides Cimzia? *

What are other side effects people have besides Retinal deposits? *

Lung Disorder (lung disease): 30 people, 96.77%
Infection: 30 people, 96.77%
Hair Loss: 30 people, 96.77%
Encephalitis Viral (inflammation of the brain due to viral infection): 30 people, 96.77%
Drug Ineffective: 30 people, 96.77%
Asthma: 30 people, 96.77%
Wheezing (a high-pitched whistling sound made while you breath): 25 people, 80.65%
Drug Effect Decreased: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Cimzia and have Retinal deposits?

- Check whether Retinal deposits is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cimzia:

Cimzia (106,745 reports)

Browse all side effects of Cimzia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinal deposits:

Retinal deposits (21 drugs)

Browse all the conditions that are associated with Retinal deposits:

Retinal deposits (67 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on certolizumab pegol (the active ingredients of Cimzia) and Cimzia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.